An interventional study of OPTI-VENT Bundle and Transition in Cardiac Arrest (CA), sponsored by Children's Hospital of Philadelphia. Recruiting at 20 sites in United States. Open to participants aged 37 Weeks to 18 Years. Per ClinicalTrials.gov, last updated 2026-10-21.
Sponsored by Children's Hospital of Philadelphia · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 10 studies in Heart Arrest by Children's Hospital of Philadelphia — 4 open to participants now, 4 under way, none of them phase 3. Heart Arrest · Children's Hospital of Philadelphia.
Among the 10 studies in Heart Arrest by Children's Hospital of Philadelphia, this one is the only one that started in 2025, is one of 5 with no phase, and was the 8th registered.
927 studies on the registry are indexed under Heart Arrest; 227 are open to participants now.
Browse Heart Arrest studies →4 of the 10 studies in Heart Arrest by Children's Hospital of Philadelphia are open now, in 12 countries. Recruiting first, the newest first:
Children's Hospital of Philadelphia · Sites in United States
Ages 0 days–17 yrs
Children's Hospital of Philadelphia · Sites in United States
Ages 37 wk–18 yrs
Children's Hospital of Philadelphia · Sites in United States, Australia, Brazil and 12 more countries
Ages 0–18
By country, each count listing its studies:
Of the 157 Heart Arrest studies recruiting now, 109 (69%) set no upper age limit and 28 (18%) stop at 75 or younger; 30 take children under 18; 18 take healthy volunteers.
This study: 37 Weeks to 18 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
10 studies; the count open now beside each. This study's row is marked.
First in 2006; this study’s year is marked. 1 started in 2025.
This study's planned enrollment of 1,530 is above the median of 100 across 519 interventional studies indexed under Heart Arrest.
Median enrollment 30 across the 5 interventional studies, 89 across the 5 observational. Of the 6 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Children's Hospital of Philadelphia is the lead sponsor of 490 studies on the registry; 90 are open to participants now.
Of its 28 completed or terminated interventional studies of FDA-regulated products, 22 (79%) have results posted.
1 of the studies in Heart Arrest by Children's Hospital of Philadelphia that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07707037Children's Hospital of PhiladelphiaRemoving Surrogates Uncertainty to Reduce Fear and Anxiety After Cardiac Events - Kids | 2027-05-31 |
Add it to your calendar (.ics) → With an account.
Among the 10 studies in Heart Arrest by Children's Hospital of Philadelphia, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Pediatric cardiac arrest is a life-threatening problem affecting >15,000 hospitalized children each year. Less than half of these children survive to hospital discharge, and neurologic morbidity is common among survivors. The objective of this study is to evaluate the effectiveness of the OPTI-VENT bundle to improve survival to discharge with favorable neurological outcome (Pediatric Cerebral Performance Category Score 1-2 or no change from baseline) among children receiving at least 1 minute of CPR.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Standard ICU resuscitation practices throughout study
Other: None - control
Provider Education: During a brief (\<2 minute) bedside education, the educator will 1) review the CPR ventilation rate targets for age, and 2) ensure the provider has a cue card of current rate recommendations on his/her person. Compliance will be defined as performance of at least 30 trainings per unit per month. We will record provider discipline and time since last training as a surrogate of training spread. Educators will leverage these two-minute trainings to review the patient's current ventilator settings as an initial target during CPR to ensure adequate chest rise. Additionally, a focus on CPR ventilation rates will be integrated into resuscitation education or quality meetings for all disciplines. "Report cards" detailing unit-level performance will be generated by the study team for review during site monthly presentations. Point-of-Care Guidance: A metronome will be deployed to all cardiac arrests using a smart phone application.
Other: OPTI-VENT Bundle
Study enrollment will begin on the control arm. There will be a 2-month transition period as they onboard to the intervention. And the remainder of the study period will be on the OPTI-VENT Bundle intervention.
Other: OPTI-VENT Bundle · Other: Transition · Other: None - control
Study enrollment will begin on the control arm. There will be a 2-month transition period as they onboard to the intervention. And the remainder of the study period will be on the OPTI-VENT Bundle intervention.
Other: OPTI-VENT Bundle · Other: Transition · Other: None - control
Study enrollment will begin on the control arm. There will be a 2-month transition period as they onboard to the intervention. And the remainder of the study period will be on the OPTI-VENT Bundle intervention.
Other: OPTI-VENT Bundle · Other: Transition · Other: None - control
Study enrollment will begin on the control arm. There will be a 2-month transition period as they onboard to the intervention. And the remainder of the study period will be on the OPTI-VENT Bundle intervention.
Other: OPTI-VENT Bundle · Other: Transition · Other: None - control
Study enrollment will begin on the control arm. There will be a 2-month transition period as they onboard to the intervention. And the remainder of the study period will be on the OPTI-VENT Bundle intervention.
Other: OPTI-VENT Bundle · Other: Transition · Other: None - control
Study enrollment will begin on the control arm. There will be a 2-month transition period as they onboard to the intervention. And the remainder of the study period will be on the OPTI-VENT Bundle intervention.
Other: OPTI-VENT Bundle · Other: Transition · Other: None - control
Study enrollment will begin on the control arm. There will be a 2-month transition period as they onboard to the intervention. And the remainder of the study period will be on the OPTI-VENT Bundle intervention.
Other: OPTI-VENT Bundle · Other: Transition · Other: None - control
Study enrollment will begin on the control arm. There will be a 2-month transition period as they onboard to the intervention. And the remainder of the study period will be on the OPTI-VENT Bundle intervention.
Other: OPTI-VENT Bundle · Other: Transition · Other: None - control
Study enrollment will begin on the control arm. There will be a 2-month transition period as they onboard to the intervention. And the remainder of the study period will be on the OPTI-VENT Bundle intervention.
Other: OPTI-VENT Bundle · Other: Transition · Other: None - control
Study enrollment will begin on the control arm. There will be a 2-month transition period as they onboard to the intervention. And the remainder of the study period will be on the OPTI-VENT Bundle intervention.
Other: OPTI-VENT Bundle · Other: Transition · Other: None - control
Study enrollment will begin on the control arm. There will be a 2-month transition period as they onboard to the intervention. And the remainder of the study period will be on the OPTI-VENT Bundle intervention.
Other: OPTI-VENT Bundle · Other: Transition · Other: None - control
Study enrollment will begin on the control arm. There will be a 2-month transition period as they onboard to the intervention. And the remainder of the study period will be on the OPTI-VENT Bundle intervention.
Other: OPTI-VENT Bundle · Other: Transition · Other: None - control
Provider Education: During a brief (\<2 minute) bedside education, the educator will 1) review the CPR ventilation rate targets for age, and 2) ensure the provider has a cue card of current rate recommendations on his/her person. Compliance will be defined as performance of at least 30 trainings per unit per month. We will record provider discipline and time since last training as a surrogate of training spread. Educators will leverage these two-minute trainings to review the patient's current ventilator settings as an initial target during CPR to ensure adequate chest rise. Additionally, a focus on CPR ventilation rates will be integrated into resuscitation education or quality meetings for all disciplines. "Report cards" detailing unit-level performance will be generated by the study team for review during site monthly presentations. Point-of-Care Guidance: A metronome will be deployed to all cardiac arrests using a smart phone application.
There will be a 2-month transition period for study sites beginning study enrollment using standard ICU practices as they onboard to the study intervention.
Control - no intervention
Survival with a favorable neurologic outcome
Survival to hospital discharge with a favorable neurologic outcome (Pediatric Cerebral Performance Category (PCPC) score (scored on a scale of 1-6) at hospital discharge of 1 (normal), 2 (mild disability) or no worse than baseline). Percentage of subjects in control vs. intervention will be compared.
Time frame: From baseline (assessed prior to admission, or new in-hospital baseline assessed no more than 30 days prior to cardiac arrest for patients hospitalized >90 days) to the assessment at hospital discharge, estimated average of 6-12 months
Ventilation rate
Intra-arrest ventilation rate between 18 - 32 breaths per minute. Ventilation rate will be calculated as an event average, excluding the first two minutes of the event. Percentage of events achieving target in control vs. intervention will be compared.
Time frame: Two minutes after CPR start through end of CPR
Return of spontaneous circulation (ROSC) lasting >20 minutes
Percentage of events achieving ROSC in control vs. intervention will be compared.
Time frame: Duration of CPR event through 20 minutes after CPR
Return of circulation (via ROSC or eCPR)
Percentage of events achieving return of circulation in control vs. intervention will be compared.
Time frame: Duration of CPR event through 20 minutes after CPR
Survival to discharge
Percentage of subjects surviving to discharge in control vs. intervention will be compared.
Time frame: From cardiac arrest to hospital discharge, estimated average of 6-12 months
Survival with no new morbidity (change in Functional Status Score (FSS) from baseline of < 3 points)
FSS is scored on a scale of 1-5 (lower number is better function) across 6 functional categories (mental status, sensory, communication, motor function, feeding, respiratory). Percentage of subjects surviving with no new morbidity in control vs. intervention will be compared.
Time frame: From baseline (assessed prior to admission, or new in-hospital baseline assessed no more than 30 days prior to cardiac arrest for patients hospitalized >90 days) to the assessment at hospital discharge, estimated average of 6-12 months
Intra-arrest cerebral oxygen saturation
Intra-arrest cerebral oxygen saturation as a continuous variable will be compared between intervention and control.
Time frame: Duration of CPR event
Intra-arrest diastolic blood pressure (DBP)
Invasive arterial blood pressure (mmHg) as a continuous variable will be compared between intervention and control.
Time frame: Duration of CPR event
Intra-Arrest Diastolic Blood Pressure (DBP) Target
Percentage of patients achieving DBP targets (\>25mmHg in infants \< 1 year of age; \>30mmHg in older children) will be compared between control vs. intervention.
Time frame: Duration of CPR
Hyperoxia (PaO2 >300 mmHg)
Percentage of subjects in control vs. intervention will be compared.
Time frame: During the first 24 hours after return of circulation.
Hypocarbia (PaCO2 <30 mmHg)
Percentage of subjects in control vs. intervention will be compared.
Time frame: During the first 24 hours after return of circulation.
Plan to share: Yes — We plan to make a public use dataset available on the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Data and Specimen Hub (DASH) at the conclusion of the study. The public use data set will contain a randomly generated subject identification number but will not contain any personal or site identifiers. The cleaned, item-level spreadsheet data for all variables will be shared openly. Final files used to generate specific analyses to answer the Specific Aims and related results will also be shared. All study documents will be made available along with the public use data set. The study protocol and statistical analysis plan will be shared publicly. To facilitate interpretation of the data, a data dictionary will be created, shared, and associated with the relevant datasets.
Started Oct 2025 (actual). Primary completion is estimated for Mar 2030, 53 months after the start.
Of 205 non-industry interventional studies with no phase under Heart Arrest, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 47. This study's planned 53 months is above that.
Counting every sponsor, half of 219 studies reached it within 28 months; a quarter within 10 and three quarters within 48.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Children's Hospital of Philadelphia →